Gautam Raju, Saklani Arvind, Jachak Sanjay M
Department of Natural Products, National Institute of Pharmaceutical Education and Research (NIPER), Sector-67, SAS Nagar (Mohali) 160062, Punjab, India.
J Ethnopharmacol. 2007 Mar 21;110(2):200-34. doi: 10.1016/j.jep.2006.12.031. Epub 2007 Jan 4.
It is estimated that one-third of the world's population is infected with tubercle bacillus and the problem of tuberculosis (TB) has been intensified due to HIV pandemic providing a large reservoir of highly susceptible individuals. Since no anti-TB drugs have been introduced in past 30 years, there is an urgent need to search for and develop new, effective and affordable anti-TB drugs. In this scenario, the plant kingdom with enormous chemical diversity may be looked as an important source of new anti-TB agents. Of 17,500 higher plant species occurring in India only about 365 species have been evaluated so far for antimycobacterial activity. The present review article describes the 255 (70% of 365) plant species from a wide range of families that have shown antimycobacterial activity. The species are enumerated in table format describing plant species and family, plant part used, type of extract and in vitro activity (MIC value), information on active compounds, if any, and uses in the ethnomedicine and Ayurveda. Interestingly, most of the plant species have shown strong positive ethnopharmacological correlation with the traditional knowledge. In addition, the recent in vitro screening methods for antimycobacterial activity are also described in brief. An attempt has been made to highlight the promising plant species for further investigation as leads for drug development.
据估计,世界三分之一的人口感染了结核杆菌,由于艾滋病大流行导致大量高易感人群的存在,结核病问题日益严重。由于过去30年没有引入新的抗结核药物,迫切需要寻找和开发新的、有效且价格合理的抗结核药物。在这种情况下,具有巨大化学多样性的植物界可被视为新抗结核药物的重要来源。在印度发现的17500种高等植物物种中,迄今为止只有约365种进行了抗分枝杆菌活性评估。本综述文章描述了来自广泛科属的255种(占365种的70%)具有抗分枝杆菌活性的植物物种。这些物种以表格形式列举,描述了植物物种和科属、使用的植物部位、提取物类型和体外活性(MIC值)、活性化合物信息(如有)以及在民族医学和阿育吠陀医学中的用途。有趣的是,大多数植物物种与传统知识显示出强烈的正民族药理学相关性。此外,还简要描述了最近的抗分枝杆菌活性体外筛选方法。已尝试突出有前景的植物物种,以供进一步研究作为药物开发的先导。